← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2008Last known activity
Jan 2, 2026
Timeline
2000s
- Mar 3, 2000
Ilsan Hospital— Founded
Drugs by trial phase (26 distinct, 20 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Adenomyosis
- Alzheimer Disease
- Anemia
- Coronary Artery Disease
- Essential Hypertension
- Glomerulonephritis
- Hepatitis
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypertension
- Intermittent Claudication
- Kidney Diseases
- Kidney Failure, Chronic
- Leiomyoma
- Myofibroma
- Nausea
- Neuralgia
- Ovarian Neoplasms
- Peripheral Arterial Disease
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Spinal Cord Injuries
- Ureteral Calculi
- Ureterolithiasis
- Vomiting
- Wounds and Injuries
Recent trials (26)
- NCT07251101Lead sponsorN/AJan 2, 2026
- NCT07251101Sponsor investigatorN/AJan 2, 2026
- NCT06990568Sponsor investigatorPhase 4Jun 1, 2025
- NCT06990568Lead sponsorPhase 4Jun 1, 2025
- NCT06920810Lead sponsorPhase 4Mar 19, 2025
- NCT06920810Sponsor investigatorPhase 4Mar 19, 2025
- NCT06081803CollaboratorPhase 3Dec 5, 2020
- NCT03357653CollaboratorPhase 3Jan 30, 2018
- NCT02799368CollaboratorPhase 3Nov 1, 2016
- NCT02350959Overall official - principal investigatorPhase 4Jan 1, 2015
- NCT02350959Lead sponsorPhase 4Jan 1, 2015
- NCT02350959Reponsible party - principal investigatorPhase 4Jan 1, 2015
- NCT02011659Reponsible party - principal investigatorPhase 3Nov 1, 2013
- NCT02011659Lead sponsorPhase 3Nov 1, 2013
- NCT01871792CollaboratorPhase 4Jun 1, 2013
Details
- Founded
- Goyang, KR Mar 3, 2000
- Last known activity
- Jan 2, 2026